Horizon Investments, LLC Bio Rad Laboratories, Inc. Transaction History

Horizon Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$268.26 - $339.48 $804 - $1,018	-3 Reduced 0.8%	371 $101,000
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $1,520 - $1,759	-5 Reduced 1.32%	374 $129,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $16,162 - $21,902	60 Added 18.81%	379 $122,000
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $1,751 - $2,113	5 Added 1.59%	319 $114,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $3,594 - $4,864	-10 Reduced 3.09%	314 $119,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $135,655 - $162,972	324 New	324 $155,000
Q4 2021 Feb 15, 2022	SELL	$708.84 - $794.68 $297,712 - $333,765	-420 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $276,238 - $346,823	420 New	420 $313,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Investments, LLC with notifications on news.